Literature DB >> 16907841

Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.

U Hedner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16907841     DOI： 10.1111/j.1538-7836.2006.02166.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  8 in total

Review 1.  Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date.

Authors:  Muriel Giansily-Blaizot; Jean-François Schved
Journal:  Ther Adv Hematol       Date:  2017-11-03

2.  Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.

Authors:  Irene Lopez-Vilchez; Ulla Hedner; Carmen Altisent; Maribel Diaz-Ricart; Gines Escolar; Ana M Galan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

3.  Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors:  Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal:  Blood Adv       Date:  2019-02-12

4.  The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?

Authors:  Raul Altman; Alejandra Scazziota; Maria de Lourdes Herrera; Claudio D Gonzalez
Journal:  Thromb J       Date:  2010-05-05

Review 5.  The role of tissue factor and factor VIIa in hemostasis.

Authors:  Nigel Mackman
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

Review 6.  Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.

Authors:  Ulla Hedner; Nikolai C Brun
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

7.  Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality.

Authors:  Majed N Aljamali; Paris Margaritis; Alexander Schlachterman; Shing Jen Tai; Elise Roy; Ralph Bunte; Rodney M Camire; Katherine A High
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors.

Authors:  Ampaiwan Chuansumrit; Pantep Angchaisuksiri; Nongnuch Sirachainan
Journal:  J Blood Med       Date:  2010-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.